Microneedle-based ocular drug delivery systems – recent advances and challenges

Abstract

Eye diseases and injuries constitute a significant clinical problem worldwide. Safe and effective delivery of drugs to the eye is challenging mostly due to the presence of ocular barriers and clearance mechanisms. In everyday practice, the traditional eye drops, gels and ointments are most often used. Unfortunately, they are usually not well tolerated by patients due to the need for frequent use as well as the discomfort during application. Therefore, novel drug delivery systems with improved biopharmaceutical properties are a subject of ongoing scientific investigations. Due to the developments in microtechnology, in recent years, there has been a remarkable advance in the development of microneedle-based systems as an alternative, non-invasive form for administering drugs to the eye. This review summarizes the latest achievements in the field of obtaining microneedle ocular patches. In the manuscript, the most important manufacturing technologies, microneedle classification, and the research studies related to ophthalmic application of microneedles are presented. Finally, the most important advantages and drawbacks, as well as potential challenges related to the unique anatomy and physiology of the eye are summarized and discussed.

Incorporation of Inclusion Complexes in the Dissolvable Microneedle Ocular Patch System for the Efficiency of Fluconazole in the Therapy of Fungal Keratitis

“…Additionally, it promotes rapid corneal healing, is minimally invasive, and tends to be more acceptable for patients uncomfortable with injections or implants. Furthermore, it holds promise for long-acting therapies, enhancing patient compliance and reducing the need for frequent drug administration. − …”

Ocular Delivery of Therapeutic Proteins: A Review

“…Ocular microneedles are popular delivery techniques exhibiting passive delivery of molecules via arrays of solid microneedles coated with drug formulations that dissolve a few minutes after insertion [ 267 , 268 ]. This technique is used as routine in clinic and is gaining popularity among formulators for having the potential to deliver ocular therapeutics, overcoming the transport barriers of epithelial tissues, eliminating clearance by conjunctival mechanisms, and minimizing retinal damage.…”

Innovative Strategies for Drug Delivery to the Ocular Posterior Segment

“…They provide passive diffusion of therapeutics, overcoming the transport barriers of epithelial tissues, eliminating clearance by conjunctival mechanisms, and minimizing retinal damage [ 79 ]. The most common microneedle classifications are based on geometry, the material applied to obtain the systems, the method of fabrication, the drug loading technique, and the mode of drug delivery [ 235 ].…”